Glypican 1 is widely expressed in pancreatic cancer, glioma, and breast carcinoma, and low levels of glypican 1 inhibit metastasis, growth, and tumorigenicity [13]. This evidence concerns the gene GPC1 and familial pancreatic carcinoma.